WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration’s expanded approval of the treatment, drug maker Novartis announced Tuesday. “The FDA approval of Kisqali for this early breastContinue Reading

WEDNESDAY, Sept. 17, 2024 (HealthDay News) — Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without insurance coverage. Because of these barriers, many people are doing an end-run around their doctor’s office, reaching outContinue Reading

 WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to moreContinue Reading